Q-linea receives first ASTar order in France

Q-linea AB (publ) (OMX: QLINEA) today announces that the company has received the first order for ASTar instruments and consumables from Eurobio Scientific in France. The instruments will be utilized at upcoming exhibitions and in future customer evaluations.

“We announced the distribution partnership in June and following product training for the French team at our headquarter in Uppsala in early July, it is very encouraging to see that market activities have picked up immediately and that our partner has placed a first order to support these. The French market is starting to adopt to rapid AST solutions for positive blood cultures and, as the first tenders are currently issued, it is a very good time to participate in evaluations and customer trials,” commented Thomas Fritz, CCO at Q-linea.

About ASTar Instrument and ASTar BC G- Kit
ASTar Instrument and ASTar BC G- Kit already deliver the broadest answer regarding the combination of the number of antibiotics and the number of double dilution steps of each antibiotic, in a single analysis for gram-negative bacteria. The test enables the analysis of gram-negative bacteria, including difficult-to-grow so-called fastidious bacteria, which satisfies the need for rapid and comprehensive results to support optimal treatment decisions.

ASTar Instrument and ASTar BC G- Kit are CE-marked but not FDA 510(k)-cleared and not available for sale in the United States.

Datum 2023-07-27, kl 09:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!